Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
ErcalcidiolCat. No. 4146 |
Price and AvailabilityBy clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy. |
|
Alternative Name: 25-Hydroxyvitamin D2 Chemical Name: 3β,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3,25-diol |
Biological Activity
Metabolite of vitamin D2.Certificate of Analysis / Safety Data Sheet
Certificate of Analysis: View current batch
Safety Data Sheet: View Safety Data Sheet
References
Jones et al (1976) An in vitro study of vitamin D2 hydroxylases in the chick. J.Biol.Chem. 251 24. PMID: 1081537.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: Ercalcidiol, supplier, Vitamin, D, receptor, VDR, agonists, Receptors, VDR-like, 25-Dihydroxyvitamin, D2
Quick Order
Find multiple products by catalog number
New Products in this Area
(R)-DPN
Enantiomer of DPN (Cat. No. 1494)
LevonorgestrelSynthetic progesterone analog
GC 1High affinity thyroid receptor α (TRα) and TRβ agonist; thyromimetic
SR 8278REV-ERBα antagonist
TCPOBOPConstitutive androstane receptor (CAR) agonist
Sign-up for new product e-alerts
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.




